Have a personal or library account? Click to login
Efficacy of Genital Chlamidiae Trachomatis Treatment in Women of Reproductive Age Cover

Efficacy of Genital Chlamidiae Trachomatis Treatment in Women of Reproductive Age

Open Access
|Jul 2018

References

  1. 1. Thompson, Sumner E., and A Eugene Washington. Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiologic reviews 5 (1983): 96.10.1093/oxfordjournals.epirev.a036266
  2. 2. Walker, Jennifer, et al. Chlamydia trachomatis incidence and re-infection among young women–behavioural and microbiological characteristics. PloS one 7.5 (2012): e37778.10.1371/journal.pone.0037778
  3. 3. Weinstock, Hillard, Stuart Berman, and Willard Cates. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspectives on sexual and reproductive health 36.1 (2004): 6-10.10.1363/3600604
  4. 4. Stamm, Walter E. Chlamydia trachomatis infections: progress and problems. Journal of Infectious Diseases 179.Supplement 2 (1999): S380-S383.10.1086/513844
  5. 5. Fenton, Kevin A., et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. The Lancet 358.9296 (2001): 1851-1854.10.1016/S0140-6736(01)06886-6
  6. 6. Morré, Servaas A., et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after oneyear follow-up. International journal of STD & AIDS 13.suppl 1 (2002): 12-18.10.1258/095646202762226092
  7. 7. Cates, Willard, and Judith N. Wasserheit. Genital chlamydial infections: epidemiology and reproductive sequelae. American journal of obstetrics and gynecology 164.6 (1991): 1771-1781.10.1016/0002-9378(91)90559-A
  8. 8. Satterwhite, Catherine Lindsey, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sexually transmitted diseases 40.3 (2013): 187-193.10.1097/OLQ.0b013e318286bb5323403598
  9. 9. de Figueirêdo, Camila Macêdo, et al. Analysis Of Scientific Production On Ophthalmia Case Study Of Newborn And Its Relationship With The Type Of Birth And Preventive Methods: Systematic Review And Meta-Analysis. International Archives of Medicine 9.1 (2016).
  10. 10. Ferreira, Glenda Roberta Oliveira Naiff. Soroepidemiologia de Chlamydia trachomatis, Chlamydia pneumoniae e Treponema pallidum nas aldeias indígenas Bakajá, Apyterewa, Xingu e Mrotidjãm, Altamira, Pará, Brasil. (2010).
  11. 11. Haggerty, Catherine L., et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. Journal of Infectious diseases 201.Supplement 2 (2010): S134-S155.10.1086/65239520470050
  12. 12. Jaschek, G., et al. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. Journal of clinical microbiology 31.5 (1993): 1209-1212.10.1128/jcm.31.5.1209-1212.19932629058501220
  13. 13. Morré, S. A., et al. Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?. Journal of Clinical Microbiology 38.6 (2000): 2292-2296.10.1128/JCM.38.6.2292-2296.2000
  14. 14. Lee, Helen H., et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. The Lancet 345.8944 (1995): 213-216.10.1016/S0140-6736(95)90221-X
  15. 15. Stephens, R. S., et al. Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. The Journal of Immunology 128.3 (1982): 1083-1089.10.4049/jimmunol.128.3.1083
  16. 16. Ratti, Giulio. Chlamydia trachomatis antigens. U.S. Patent No. 8,114,401. 14 Feb. 2012.
  17. 17. Chen, Ding, et al. Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen. Journal of bacteriology 192.22 (2010): 6017-6024.10.1128/JB.00847-10297643820851898
  18. 18. Baud, D., L. Regan, and G. Greub. Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies. European journal of clinical microbiology & infectious diseases 29.6 (2010): 669-675.10.1007/s10096-010-0912-420349260
  19. 19. Stevens, Matthew P., et al. Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination. Journal of clinical microbiology 48.6 (2010): 2060-2065.10.1128/JCM.02308-09288450020392903
  20. 20. Horner, Paddy J. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. Sexually transmitted infections 88.3 (2012): 154-156.10.1136/sextrans-2011-05038522416272
  21. 21. Lanjouw, E., et al. 2010 European guideline for the management of Chlamydia trachomatis infections. International journal of STD & AIDS 21.11 (2010): 729-737.10.1258/ijsa.2010.01030221187352
  22. 22. Bhengraj, Apurb Rashmi, et al. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India. Chemotherapy 56.5 (2010): 371-377.10.1159/00031499820938174
  23. 23. Pitsouni, Eleni, et al. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. International journal of antimicrobial agents 30.3 (2007): 213-221.10.1016/j.ijantimicag.2007.04.01517596917
  24. 24. Hathorn, Emma, Catherine Opie, and Penny Goold. What is the appropriate treatment for the management of rectal Chlamydia trachomatis in men and women?. Sexually transmitted infections 88.5 (2012): 352-354.10.1136/sextrans-2011-05046622517887
  25. 25. Thorpe, E. M., et al. Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises. Genitourinary medicine 72.2 (1996): 93-97.10.1136/sti.72.2.9311956158698374
  26. 26. Schwebke, J. R., et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens–a randomized clinical trial. Clinical Infectious Diseases 52.2 (2011): 163-170.10.1093/cid/ciq074310625221288838
  27. 27. Kong, F. Y. S., et al. Azithromycin versus doxycycline for the treatment of genital chlamydia infection–a meta-analysis of randomised controlled trials. Clinical Infectious Diseases (2014): ciu220.10.1093/cid/ciu22024729507
  28. 28. Kong, Fabian Yuh Shiong, and Jane Simone Hocking. Treatment challenges for urogenital and anorectal Chlamydia trachomatis. BMC infectious diseases 15.1 (2015): 1.10.1186/s12879-015-1030-9451851126220080
  29. 29. Kissinger, Patricia J., et al. Azithromycin treatment failure for Chlamydia trachomatis among heterosexual men with nongonococcal urethritis. Sexually Transmitted Diseases 43.10 (2016): 599-602.10.1097/OLQ.0000000000000489503350727631353
  30. 30. Lau, Chuen-Yen, and Azhar K. Qureshi. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sexually transmitted diseases 29.9 (2002): 497-502.10.1097/00007435-200209000-0000112218839
  31. 31. Rustomjee, Roxana, et al. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. Journal of Antimicrobial Chemotherapy 49.5 (2002): 875-878.10.1093/jac/dkf03412003988
  32. 32. Gambini, Daniele, et al. Mycoplasma genitaliumin Males With Nongonococcal Urethritis: Prevalence and Clinical Efficacy of Eradication. Sexually transmitted diseases 27.4 (2000): 226-229.10.1097/00007435-200004000-0000810782745
  33. 33. Ibrahim Salah Eldin. Evaluation Of Azithromycin In Treatment Of Avulgaris. Diss. UOFK, 2015.
  34. 34. Manhart, Lisa E., et al. Efficacy of antimicrobial therapy for Mycoplasma genitalium infections. Clinical Infectious Diseases 61.suppl 8 (2015): S802-S817.10.1093/cid/civ78526602619
  35. 35. Perletti, Gianpaolo, et al. Antimicrobial therapy for chronic bacterial prostatitis. The Cochrane Library (2013).10.1002/14651858.CD009071.pub223934982
  36. 36. Haddix, Anne C., Susan D. Hillis, and William J. Kassler. The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women. Sexually Transmitted Diseases 22.5 (1995): 274-280.10.1097/00007435-199509000-000027502180
  37. 37. Genc, Mehmet, and Per-Anders Mardh. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Annals of Internal Medicine 124.1_Part_1 (1996): 1-7.10.7326/0003-4819-124-1_Part_1-199601010-00001
DOI: https://doi.org/10.1515/sjecr-2016-0092 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 151 - 157
Submitted on: Nov 29, 2016
Accepted on: Nov 30, 2016
Published on: Jul 17, 2018
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Aleksandra Dimitrijevic, Zoran Protrka, Nikola Jovic, Petar Arsenijevic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.